Veterinary Excipients Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Application, By Chemical Group, By Animal Type, By End Use, By Region & Competition, 2021-2031F

The Global Veterinary Excipients Market is projected to expand from USD 2.11 Billion in 2025 to USD 2.81 Billion by 2031, reflecting a compound annual growth rate of 4.82%. These excipients are pharmacologically inert substances formulated with active pharmaceutical ingredients to improve the stability, bioavailability, and taste of animal health products. The market's expansion is primarily driven by the escalating global demand for animal-derived protein and a substantial increase in companion animal ownership, which requires sophisticated therapeutic options. Furthermore, the rising incidence of zoonotic diseases has accelerated the need for effective veterinary formulations, thereby boosting the demand for functional excipients. Data from the American Pet Products Association indicates that total U.S. pet industry expenditures hit $152 billion in 2024, demonstrating the strong financial dedication of owners to animal welfare that supports this sector's growth.

Despite these positive conditions, the market encounters a major hurdle due to strict and varying regulatory frameworks across different regions. Manufacturers face the challenge of adhering to complex compliance standards established by authorities such as the FDA and EMA, which can extend development timelines and inflate production costs. This regulatory complexity acts as a formidable barrier to entry for new excipients, potentially curbing innovation and restricting the availability of cost-effective solutions in emerging markets where veterinary standards are currently evolving.

Market Driver

The trends of rising global pet ownership and the humanization of animals are fundamentally altering the veterinary excipients landscape by accelerating the demand for sophisticated oral solid dosage forms and palatable delivery systems. As pet owners increasingly regard their companions as family members, there is a distinct shift toward treating chronic conditions such as arthritis and diabetes, necessitating long-term medication adherence. This trend compels manufacturers to utilize advanced functional excipients, particularly taste-masking agents and disintegrants, to transform traditional veterinary drugs into pet-friendly chewables and treats. The financial commitment to advanced veterinary care is evident in the surging insurance sector; according to the North American Pet Health Insurance Association's 'State of the Industry Report 2024' released in April 2024, total pet insurance premiums in North America reached a record $4.27 billion in 2023, signaling a robust market for premium pharmaceutical formulations.

Simultaneously, the expansion of intensive livestock farming operations acts as a parallel driver, creating high-volume demand for cost-effective excipients used in vaccines, medicated feed additives, and injectables. To maintain productivity and food security within densely populated herds, producers rely heavily on prophylactic treatments, where excipients act as critical stabilizers and carriers to ensure drug efficacy under field conditions. This reliance is underscored by production forecasts; according to the USDA Foreign Agricultural Service's October 2024 'Livestock and Poultry: World Markets and Trade' report, global chicken meat exports are forecast to rise to a record 13.8 million tons in 2025, reflecting the intense pressure on production systems that sustains the bulk excipient market. The immense scale of pharmaceutical requirements in this sector is further highlighted by leading manufacturers; according to Zoetis, in 2024, the company reported full-year revenue of $8.5 billion for 2023, illustrating the substantial industrial footprint requiring a steady supply of pharmaceutical ingredients.

Market Challenge

The stringent and fragmented regulatory landscape across different regions constitutes a primary obstacle hampering the growth of the Global Veterinary Excipients Market. Manufacturers must adhere to disparate compliance requirements enforced by agencies such as the FDA and EMA, which often necessitates extensive and redundant validation processes for excipient safety and efficacy. This regulatory divergence significantly escalates production costs and prolongs development timelines, thereby reducing the speed at which novel excipients can be integrated into finished veterinary formulations. These elevated resource demands act as a substantial barrier to entry, disproportionately affecting smaller enterprises and stifling the overall rate of innovation within the industry.

Furthermore, the complexity of securing regulatory approval limits the availability of advanced therapeutic options in key markets where cost-efficiency is paramount. The inability to rapidly deploy compliant formulations directly affects the productivity of end-use sectors that rely heavily on accessible veterinary medicines. According to Animal Medicines Australia, in 2024, the livestock industry was forecast to contribute $37.6 billion to agricultural production, a figure that highlights the critical economic volume dependent on the efficient approval and supply of high-quality animal health products. Consequently, regulatory inefficiencies not only hinder market expansion but also threaten the economic stability of the industries these excipients serve.

Market Trends

The development of high-purity excipients is accelerating due to the rapid expansion of the veterinary biologics sector, particularly for monoclonal antibodies and large-molecule vaccines. Unlike traditional small-molecule drugs, these complex formulations require specialized stabilizing agents, such as pharmaceutical-grade surfactants, buffers, and cryoprotectants, to maintain efficacy during freeze-drying and storage. This technical necessity is driving significant capital expenditure in manufacturing capabilities designed specifically to handle sensitive biological ingredients, distinct from standard chemical production. According to Merck Animal Health, May 2025, in the press release 'Merck Animal Health and State of Kansas Announce $895 Million Investment', the company committed $895 million to expand its De Soto, Kansas facility, specifically enhancing filling and freeze-drying capacity for biologics and vaccines.

Concurrently, the market is witnessing a fundamental shift toward sustainable and biodegradable excipients, compelled by the rigorous environmental, social, and governance (ESG) mandates of leading animal health corporations. Manufacturers are increasingly scrutinizing their supply chains to reduce Scope 3 emissions, prioritizing ingredients derived from renewable sources over petrochemical-based polymers to minimize their environmental impact. This industry-wide decarbonization strategy creates a cascading requirement for excipient suppliers to validate the carbon footprint and biodegradability of their portfolios to remain compliant with major procurement standards. According to Zoetis, June 2025, in the '2024 Sustainability Progress Update', the company reported sourcing 80.6% of its global electricity from renewable sources, illustrating the scale of the green transition that is reshaping procurement criteria for pharmaceutical ingredients.

Key Market Players

• Croda International plc
• JRS PHARMA GmbH + Co. KG
• Colorcon
• Quality Chemicals S.L
• IOI Oleo GmbH
• Lipoid GmbH
• Gattefosse SAS
• Azelis Group
• Ashland Global Holdings Inc.
• Spectrum Chemical Mfg. Corp.

Report Scope

In this report, the Global Veterinary Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Excipients Market, By Application

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

Veterinary Excipients Market, By Chemical Group

• Polymers
• Alcohols
• Lipids
• Mineral Salts
• Others

Veterinary Excipients Market, By Animal Type

• Production Animals
• Companion Animals

Veterinary Excipients Market, By End Use

• Solubilizers/ Solvents
• Binders
• Stabilizers
• Coating
• Diluents & fillers
• Others

Veterinary Excipients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Excipients Market.

Available Customizations:

Global Veterinary Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).